cefepime


Also found in: Medical, Wikipedia.
Related to cefepime: Cefixime

cef·e·pime

 (sĕf′ə-pēm′)
n.
A broad-spectrum cephalosporin antibiotic, C19H24N6O5S2, used in its hydrochloride form to treat a variety of infections, including skin and urinary tract infections and certain types of pneumonia.

[cef(a)- + probably (m)e(thyl) + p(yrrole) + (ox)ime.]
Translations

cefepime

n cefepima
References in periodicals archive ?
Potency and spectrum trends for cefepime tested against 65,746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
All non-O157 STEC strains were susceptible to 5 antimicrobial drugs (ceftazidime, ciprofloxacin, cefotaxime, cefepime, and cefoxitin).
Forward-looking statements in this news release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the demand, supply and distribution of cefepime hydrochloride for injection.
MDR Gram-negative strains were defined to be resistant to meropenem, piperacillin-tazobactam, cefepime, amoxicillin-clavulanic acid and amikacin.
On June 18, 2007, the first generic formulation of cefepime hydrochloride was approved by the FDA.
Antibiotic susceptibility to newer antibiotics ([micro]g) like piperacillin (100), cefepime (30), imipenem (10 [micro]g), aztreonam (30 [micro]g) and [beta]-lactam [beta]-lactamase inhibitor combinations such as amoxycillin-clavulanic acid (30/10), ampicillin-sulbactam (10/10), piperacillin-tazobactam (100/10) and ceftazidime-clavulanic acid (30/10) was performed by the NCCLS method (11).
pneumoniae (N=503) (N=548) Antibiotic Overall (range) Overall (range) Ampicillin 82 (65-90) 100 (-) Co-amoxiclav 39 (0-57) 62 (31-73) Cefuroxime 18 (0-33) 62 (31-72) Ceftriaxone/cefotaxime 7 (0-15) 57 (43-66) Cefepime 5 (0-14) 54 (50-64) Piperacillin-tazobactam 9 (0-23) 49 (26-67) Ciprofloxacin 16 (0-36) 39 (18-64) Levofloxacin 16 (0-36) 39 (28-64) Gentamicin 14 (0-32) 31 (0-43) Amikacin 6 (0-15) 25 (8-50) Ertapenem 2 (0-8) 2 (0-8) Imipenem 1 (0-6) 1 (0-1) Meropenem 1 (0- 6) 1 (0-1) % ESBL production 5 (0-11) 50 (33-59) Enterobacter spp.
cefotaxime (30), ceftriaxone (30), cefoperazone (30), cefepime (30), cotrimoxazole (25), amikacin (30), gentamicin (10), ciprofloxacin (5), piperacillin (100), ceftazidime/clavulanate (30/10), cefoperazone/sulbactam (75/35) and imipenem (10).
Susceptibility to 10 single antipseudomonal antibiotics (piperacillin, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, ofloxacin, amikacin, gentamicin and tobramycin) and the piperacillin/ tazobactam (PIP/TAZ) combination, all supplied by Mast Diagnostics (Mast House, Derby Road, Bootle, UK) was determined by the disc diffusion method, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determinations.
6 percent resistance) was more active than four of seven studied antibiotics, behind only cefepime (2.
Demonstrated synergistic activity with cefepime and ciprofloxacin leading to more rapid killing; and
Cefepime and cefotaxime along with the clavulanate disk in the DDST detected most of the ESBLs in Acinetobacter.